| [1] |
You YN, Hardiman KM, Bafford A, et al. On behalf of the clinical practice guidelines committee of the american society of colon and rectal surgeons. The american society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer[J]. Dis Colon Rectum, 2020, 63(9): 1191-1222.
|
| [2] |
Xynos E, Tekkis P, Gouvas N, et al. Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)[J]. Annals of Gastroenterology, 2016, 29(2): 103-126.
|
| [3] |
练磊, 谢明颢. 从“两面三道”浅谈直肠癌手术侧方淋巴结清扫的技巧——复杂问题简单化的一个思考[J]. 中华胃肠外科杂志, 2019, 22(6): 597-600.
|
| [4] |
Yamaguchi T, Konishi T, Kinugasa Y, et al. Laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer: a subgroup analysis of a large multicenter cohort study in Japan[J]. Diseases of the Colon & Rectum, 2017, 60(9): 954.
|
| [5] |
Williamson JS, Quyn AJ, Sagar PM. Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management[J]. Br J Surg, 2020, 107(12): 1562-1569.
|
| [6] |
Kobayashi H, Mochizuki H, Kato T, et al. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection[J]. Diseases of the Colon & Rectum, 2009, 52(4): 567-576.
|
| [7] |
Nagawa H, Muto T, Sunouchi K, et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy[J]. Dis Colon Rectum, 2001, 44(9): 1274-1280.
|
| [8] |
Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer[J]. Am J of Surg, 1982, 144(3): 350-354.
|
| [9] |
Koyama Y, Moriya Y, Hojo K. Effects of extended systematic lymphadenectomy for adenocarcinoma of the rectum--significant improvement of survival rate and decrease of local recurrence[J]. Jpn J Clin Oncol, 1984, 14(4): 623-632.
|
| [10] |
Moriya Y, Hojo K, Sawada T, et al. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection[J]. Diseases of the Colon & Rectum, 1989, 32(4): 307-315.
|
| [11] |
Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer[J]. Int J Clin Oncol, 2020, 25(1): 1-42.
|
| [12] |
Leyh-Bannurah SR, Budäus L, Zaffuto E, et al. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification[J]. Urol Oncol, 2018, 36(2): 81.e17-81.e24.
|
| [13] |
Wisner KPA, Ahmad S, Holloway RW. Indications and techniques for robotic pelvic and para-aortic lymphadenectomy with sentinel lymph node mapping in gynecologic oncology[J]. Best Pract Res Clin Obstet Gynaecol, 2017, 45: 83-93.
|
| [14] |
Atef Y, Koedam TW, Oostendorp S, et al. Lateral pelvic lymph node metastases in rectal cancer: A systematic review[J]. World J Surg, 2019, 43(12): 3198-3206.
|
| [15] |
Otero de Pablos J, Mayol J. Controversies in the management of lateral pelvic lymph nodes in patients with advanced rectal cancer: east or west?[J]. Frontiers in Surgery, 2019, 6: 79.
|
| [16] |
EURECCA colorectal. Multidisciplinary management: European consensus conference colon & rectum[J]. Eur J Cancer, 2014, 50(1): 1.e1-1.e34.
|
| [17] |
Christou N, Meyer J, Combescure C, et al. Prevalence of metastatic lateral lymph nodes in asian patients with lateral lymph node dissection for rectal cancer: a meta-analysis[J]. World J Surg, 2021, 45(5): 1537-1547.
|
| [18] |
Sugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer[J]. Dis Colon Rectum, 2006, 49(11): 1663-1672.
|
| [19] |
Ueno M, Oya M, Azekura K, et al. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer[J]. Br J Surg, 2010, 92(6): 756-763.
|
| [20] |
Shimoyama M, Yamazaki T, Suda T, et al. Prognostic significance of lateral lymph node micrometastases in lower rectal cancer[J]. Dis Colon Rectum, 2003, 46(3): 333-339.
|
| [21] |
Yang X, Hu T, Gu C, et al. The prognostic significance of isolated tumor cells detected within lateral lymph nodes in rectal cancer patients after laparoscopic lateral lymph node dissection[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(11): 1462-1468.
|
| [22] |
Group MS. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer[J]. Br J Surg, 2011, 98(12): 1798-1804.
|
| [23] |
Akiyoshi T, Ueno M, Matsueda K, et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging[J]. Ann Surg Oncol, 2014, 21(1): 189-196.
|
| [24] |
Kasai S, Shiomi A, Kagawa H, et al. The effectiveness of machine learning in predicting lateral lymph node metastasis from lower rectal cancer: a single center development and validation study[J]. Ann Gastroenterol Surg, 2021, 6(1): 92-100.
|
| [25] |
Ma P, Yuan Y, Yan P, et al. The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: A systematic review and meta-analysis[J]. Asian Journal of Surgery, 2020, 43(9): 891-901.
|
| [26] |
Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis[J]. Lancet Oncol, 2009, 10(11): 1053-1062.
|
| [27] |
Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial[J]. Lancet Oncol, 2012, 13(6): 616-621.
|
| [28] |
Oki E, Shimokawa M, Ando K, et al. Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial[J]. Surgery, 2019, 165(3): 586-592.
|
| [29] |
Watanabe T, Tsurita G, Muto T, et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers[J]. Surgery, 2002, 132(1): 27-33.
|
| [30] |
Chew C, Hoskin P, Davies J, et al. Colorectal cancer: NICE guideline [NG151][EB/OL]. (2020-02-29)[2022-06-25].
URL
|
| [31] |
Ozawa H, Kotake K, Hosaka M, et al. Impact of lateral pelvic lymph node dissection on the survival of patients with T3 and T4 low rectal cancer[J]. World J Surg, 2016, 40(6): 1492-1499.
|
| [32] |
Ishihara S, Kanemitsu Y, Murono K, et al. Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis[J]. Int J Colorectal Dis, 2016, 31(7): 1-7.
|
| [33] |
Kim HJ, Choi GS, Park JS, et al. Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer[J]. Oncotarget, 2017, 8(59): 100724-100733.
|
| [34] |
Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis[J]. The Lancet Oncology, 2009, 10(11): 1053-1062.
|
| [35] |
Wang JP. Interpretation of the 2020 American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer[J]. Chin J Gastrointest Surg, 2021, 24(1): 27-34.
|
| [36] |
武爱文, 詹天成. 直肠癌侧方淋巴结清扫适应证相关国内外指南解读[J]. 中国实用外科杂志, 2018, 38(10): 3.
|
| [37] |
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2017, 28(suppl_4): iv22-iv40.
|
| [38] |
Mir ZM, Yu D, Merchant SJ, et al. Management of rectal cancer in Canada: an evidence-based comparison of clinical practice guidelines[J]. Can J Surg, 2020, 63(1): E27-E34.
|
| [39] |
中国结直肠癌诊疗规范(2020年版)专家组. 国家卫生健康委员会中国结直肠癌诊疗规范(2020年版)[J].中华胃肠外科杂志, 2020, 23(6): 521-539.
|
| [40] |
Ahmadi N, Brown K, Lee P, et al. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra‐mesorectal lateral lymph nodes?[J]. Colorectal Disease, 2020, 22(6): 689-693.
|
| [41] |
Williamson JS, Quyn AJ, Sagar PM. Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management[J]. Br J Surg, 2020, 107(12): 1562-1569.
|
| [42] |
Malakorn S, Yang Y, Bednarski BK, et al. Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation?[J]. Dis Colon Rectum, 2019, 62(10): 1158-1166.
|
| [43] |
Kroon HM, Malakorn S, Dudi-Venkata NN, et al. Lateral lymph node dissection after neoadjuvant (chemo)radiotherapy may improve oncological outcomes in Western patients with low rectal cancer[J]. Journal of Clinical Oncology, 2020, 38(4_suppl): 163.
|
| [44] |
Ogura A, Konishi T, Beets GL, et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy[J]. JAMA Surgery, 2019, 154(9): e192172.
|
| [45] |
Chen JN, Liu Z, Wang ZJ, et al. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer[J]. World J Gastroenterol, 2020, 26(21): 2877-2888.
|
| [46] |
刘骞, 王锡山. 直肠癌侧方淋巴结清扫手术指征和清扫范围[J]. 中国实用外科杂志, 2020, 40(3): 311-315.
|
| [47] |
Kusters M, Beets GL, Van D, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence[J]. Ann Surg, 2009, 249(2): 229-235.
|
| [48] |
Anania G, Davies RJ, Arezzo A, et al. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients[J]. Inter J Colorec Dis, 2021, 36(11): 2321-2333.
|
| [49] |
Yang X, Gu C, Hu T, et al. Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe?[J]. ANZ Journal of Surgery, 2019, 89(11): E492-E497.
|
| [50] |
Nakanishi R, Yamaguchi T, Akiyoshi T, et al. Laparoscopic and robotic lateral lymph node dissection for rectal cancer[J]. Surg Today, 2020, 50(3): 209-216.
|
| [51] |
Ryu HS, Kim J. Current status and role of robotic approach in patients with low-lying rectal cancer[J]. Ann Surg Treat Res, 2022, 103(1): 1-11.
|
| [52] |
Sun Y, Zhang Z, Zhou Y, et al. Fascial space priority approach in laparoscopy: lateral pelvic lymph node dissection for advanced low rectal cancer[J]. Tech Coloproctol, 2020, 24(4): 335-336.
|
| [53] |
Sun Y, Lian L, Zhang H, et al. The feasibility and technical strategy of a fascia space priority approach in laparoscopic lateral lymph node dissection for advanced middle and low rectal cancer: a retrospective multicentre study[J]. Wideochir Inne Tech Maloinwazyjne, 2021, 16(2): 312-320.
|
| [54] |
王锡山. 腹部无辅助切口经肛门拖出标本的机器人辅助超低位直肠前切除+双侧侧方淋巴结清扫术(王氏入路整块切除法)(附视频)[J/OL]. 中华结直肠疾病电子杂志, 2022, 11(1): 64.
|
| [55] |
Wakasugi M, Masuzawa T, Tei M, et al. Single-incision totally extraperitoneal inguinal hernia repair: our initial 100 cases and comparison with conventional three-port laparoscopic totally extraperitoneal inguinal hernia repair[J]. Surg Today, 2015, 45(5): 606-610.
|
| [56] |
Masubuchi S, Okuda J, Hamamoto H, et al. Totally extraperitoneal approach to laparoscopic lateral lymph node dissection for patients with recurrent lateral pelvic lymph nodes after rectal cancer surgery: a novel technique—MTEP LLND[J]. Surg Today, 2019, 49(11): 981-984.
|
| [57] |
Aytaç E, Özer L, Baca B, et al. Optimizing the personalized care for the management of rectal cancer: a consensus statement[J]. The Turk J Gastroenterol, 2022, 33(8): 627-663.
|
| [58] |
Miyakita H, Chan LF, Okada K, et al. Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis[J]. BMC Gastroenterology, 2022, 22(1): 334.
|
| [59] |
Zhou S, Jiang Y, Liang J, et al. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis[J]. World J Surg Oncol, 2022, 20(1): 97.
|
| [60] |
刘骞. 直肠癌侧方淋巴结清扫中国临床开展的现状[J/OL]. 中华结直肠疾病电子杂志, 2022, 11(5): 367-371.
|
| [61] |
梅世文, 周思成, 梁建伟, 等. 侧方淋巴结转移特征对中低位直肠癌患者预后评估的价值[J/OL]. 中华结直肠疾病电子杂志, 2022, 11(6): 465-473.
|